Legal & General Group Plc boosted its position in Core Laboratories N.V. (NYSE:CLB) by 1.5% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 189,893 shares of the oil and gas company’s stock after buying an additional 2,767 shares during the period. Legal & General Group Plc owned approximately 0.43% of Core Laboratories N.V. worth $19,230,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently modified their holdings of the company. State of Wisconsin Investment Board boosted its position in shares of Core Laboratories N.V. by 12.1% in the second quarter. State of Wisconsin Investment Board now owns 84,320 shares of the oil and gas company’s stock worth $8,539,000 after buying an additional 9,070 shares during the last quarter. Denver Investment Advisors LLC boosted its stake in shares of Core Laboratories N.V. by 4.5% in the second quarter. Denver Investment Advisors LLC now owns 68,061 shares of the oil and gas company’s stock valued at $6,893,000 after buying an additional 2,920 shares during the last quarter. Morningstar Investment Services LLC boosted its stake in shares of Core Laboratories N.V. by 12.6% in the second quarter. Morningstar Investment Services LLC now owns 4,774 shares of the oil and gas company’s stock valued at $484,000 after buying an additional 536 shares during the last quarter. Trillium Asset Management LLC bought a new stake in shares of Core Laboratories N.V. during the second quarter valued at $1,058,000. Finally, Ridgewood Investments LLC boosted its stake in shares of Core Laboratories N.V. by 26.4% in the second quarter. Ridgewood Investments LLC now owns 3,892 shares of the oil and gas company’s stock valued at $394,000 after buying an additional 813 shares during the last quarter.

Shares of Core Laboratories N.V. (NYSE:CLB) opened at 89.59 on Friday. The company has a market cap of $3.95 billion, a price-to-earnings ratio of 54.96 and a beta of 1.61. Core Laboratories N.V. has a 12 month low of $87.63 and a 12 month high of $125.83. The company’s 50 day moving average price is $96.43 and its 200 day moving average price is $105.73.

Core Laboratories N.V. (NYSE:CLB) last announced its quarterly earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.01. Core Laboratories N.V. had a return on equity of 49.29% and a net margin of 11.80%. The company had revenue of $163.90 million for the quarter, compared to the consensus estimate of $168.23 million. During the same quarter in the previous year, the business earned $0.35 EPS. Core Laboratories N.V.’s revenue was up 10.7% compared to the same quarter last year. On average, equities analysts expect that Core Laboratories N.V. will post $2.09 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Monday, August 14th. Investors of record on Monday, July 17th were issued a dividend of $0.55 per share. The ex-dividend date was Thursday, July 13th. This represents a $2.20 dividend on an annualized basis and a yield of 2.46%. Core Laboratories N.V.’s dividend payout ratio is presently 134.15%.

COPYRIGHT VIOLATION NOTICE: “Legal & General Group Plc Purchases 2,767 Shares of Core Laboratories N.V. (CLB)” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.watchlistnews.com/legal-general-group-plc-purchases-2767-shares-of-core-laboratories-n-v-clb/1537410.html.

Several equities research analysts have recently weighed in on CLB shares. Piper Jaffray Companies set a $97.00 price target on Core Laboratories N.V. and gave the company a “hold” rating in a research note on Wednesday, July 26th. Citigroup Inc. decreased their price target on Core Laboratories N.V. from $102.00 to $100.00 and set a “neutral” rating for the company in a research note on Wednesday, July 26th. ValuEngine raised Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Friday, August 4th. Royal Bank Of Canada set a $145.00 price target on Core Laboratories N.V. and gave the company a “buy” rating in a research note on Saturday, June 17th. Finally, Zacks Investment Research cut Core Laboratories N.V. from a “buy” rating to a “hold” rating in a research note on Friday, June 23rd. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $113.83.

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.